Safety and Activity of F14 for Management of Pain Following Total Knee Replacement

NCT03541655 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Total Knee Replacement
Postoperative Pain

Interventions

DRUG: Bupivacaine HCl
DRUG: F14 (celecoxib)

Sponsor

Arthritis Innovation Corporation